Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina T Wiebe

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nature and Science of Sleep|April 27, 2013
Sleep patterns and the risk for unipolar depression: a reviewSabrina T Wiebe, Jamie Cassoff, Reut Gruber
Nature and Science of Sleep|April 27, 2013
Sleep patterns and the risk for ADHD: a reviewJamie Cassoff, Sabrina T Wiebe, Reut Gruber
Journal of Pharmacokinetics and Pharmacodynamics|August 11, 2020
Composite midazolam and 1'-OH midazolam population pharmacokinetic model for constitutive, inhibited and induced CYP3A activitySabrina T Wiebe, Andreas D Meid, Gerd Mikus
Adolescent Medicine: State of the Art Reviews|February 10, 2011
Sleep and academic success: mechanisms, empirical evidence, and interventional strategiesReut Gruber, Sabrina T Wiebe, Samantha Ashley Wells, et al.
CNS Drugs|November 29, 2023
Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised StudiesRené Fuertig, Markus Goettel, Lena Herich, et al.
BMC Psychiatry|November 29, 2012
Contributions of circadian tendencies and behavioral problems to sleep onset problems of children with ADHDReut Gruber, Laura Fontil, Lana Bergmame, et al.
British Journal of Clinical Pharmacology|May 22, 2020
Midazolam microdosing applied in early clinical development for drug-drug interaction assessmentSabrina T Wiebe, Andreas Huennemeyer, Werner Kadus, et al.
Clinical Pharmacokinetics|June 7, 2020
Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and CimetidineSabrina T Wiebe, Thomas Giessmann, Kathrin Hohl, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nature and Science of Sleep|April 27, 2013
Sleep patterns and the risk for unipolar depression: a reviewSabrina T Wiebe, Jamie Cassoff, Reut Gruber
Nature and Science of Sleep|April 27, 2013
Sleep patterns and the risk for ADHD: a reviewJamie Cassoff, Sabrina T Wiebe, Reut Gruber
Journal of Pharmacokinetics and Pharmacodynamics|August 11, 2020
Composite midazolam and 1'-OH midazolam population pharmacokinetic model for constitutive, inhibited and induced CYP3A activitySabrina T Wiebe, Andreas D Meid, Gerd Mikus
Adolescent Medicine: State of the Art Reviews|February 10, 2011
Sleep and academic success: mechanisms, empirical evidence, and interventional strategiesReut Gruber, Sabrina T Wiebe, Samantha Ashley Wells, et al.
CNS Drugs|November 29, 2023
Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised StudiesRené Fuertig, Markus Goettel, Lena Herich, et al.
BMC Psychiatry|November 29, 2012
Contributions of circadian tendencies and behavioral problems to sleep onset problems of children with ADHDReut Gruber, Laura Fontil, Lana Bergmame, et al.
British Journal of Clinical Pharmacology|May 22, 2020
Midazolam microdosing applied in early clinical development for drug-drug interaction assessmentSabrina T Wiebe, Andreas Huennemeyer, Werner Kadus, et al.
Clinical Pharmacokinetics|June 7, 2020
Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and CimetidineSabrina T Wiebe, Thomas Giessmann, Kathrin Hohl, et al.
Pageof 1